Intel (NASDAQ: INTC | INTC Price Prediction) may be one of the most recognized names in technology, but the stock’s dramatic run from near $24 a year ago to about $46 today has outpaced underlying reality. Short sellers appear to agree. The latest short interest data shows another increase, and the stock remains the most shorted Dow Jones industrial.
The Bull Case Lacks Credibility
Bulls point to real positives: Nvidia (NASDAQ: NVDA) invested $5 billion in Intel common stock, government backing and $8.9 billion in CHIPS Act funding, and Data Center & AI segment growth of 9% year-over-year in Q4. The turnaround narrative is compelling on the surface. Yet, it just doesn’t justify the valuation or mask what is structurally broken.
Why to Bet Against: The Core Thesis
The foundry is a cash furnace. Intel Foundry lost $2.51 billion in Q4 alone, and cumulative foundry operating losses across all four quarters of 2025 totaled roughly $10.3 billion. Revenue is growing, but losses aren’t narrowing meaningfully. CEO Lip-Bu Tan acknowledged on the earnings call: “While yields are in line with our internal plans, they are still below what I want them to be.” That’s not a ringing endorsement of execution.
The core business is shrinking. The Client Computing Group (roughly 60% of revenue) declined 7% year-over-year in Q4 and was down in three of four quarters in 2025. Advanced Micro Devices’ (NASDAQ: AMD) client segment, by contrast, surged 34% year-over-year in Q4 2025. Market share is moving away from Intel.
The guidance is alarming. For Q1 2026, Intel guided revenue of $11.7 billion to $12.7 billion, which would be a significant sequential decline from Q4’s $13.67 billion. And it guided non-GAAP EPS of $0.00 and a GAAP loss of $0.21. Supply is expected to be at its tightest in Q1. This isn’t a growth story.
The valuation doesn’t fit the fundamentals. Intel trades at 85 times expected future earnings while posting a full-year net loss of $267 million. Intel’s CFO disposed of over 49,000 shares of common stock on March 2 alone at $44.88 per share. So, insiders appear to see the stock as fairly valued at best.
What Could Prove the Thesis Wrong
It might be worth reconsidering if Intel 18A yields scale faster than expected and attracts a major external foundry customer. The CEO noted firm supplier decisions could come starting in the second half of 2026. A meaningful DCAI revenue acceleration or strategic acquisition could also shift the thesis. Q2 2026 earnings will be the first real test of whether supply constraints ease as promised.
The Bottom Line
Conviction here is a 7 out of 10. Intel is not uninvestable forever, but at current prices (with analyst consensus sitting at Hold/Reduce and an average target of $47.11) the risk-reward skews bearish. Investors looking to reallocate might find AMD’s 34% revenue growth and $5.5 billion in annual free cash flow a more compelling semiconductor story right now.
Top Gaining Stocks
Top Losing Stocks